Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance

References

• Assanhou AG, Li W, Zhang L, et al. (2015). Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment. Biomaterials 73:284–95.
   PubMed Web of Science ®Google Scholar
• Chang CE, Hsieh CM, Chen LC, et al. (2018). Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer. Drug Deliv 25:632–43.
   PubMed Web of Science ®Google Scholar
• Cohen SM, Mukerji R, Timmermann BN, et al. (2012). A novel combination of withaferin A and sorafenib shows synergistic efficacy against both papillary and anaplastic thyroid cancers. Am J Surg 204:895–901.
   PubMed Web of Science ®Google Scholar
• Duan X, Xiao J, Yin Q, et al. (2013). Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram. ACS Nano 7:5858–69.
   PubMed Web of Science ®Google Scholar
• Fletcher JI, Haber M, Henderson MJ, et al. (2010). ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer 10:147–56.
   PubMed Web of Science ®Google Scholar
• Gou Y, Zhang Z, Li D, et al. (2018). HSA-based multi-target combination therapy: Regulating drugs’ release from HSA and overcoming single drug resistance in a breast cancer model. Drug Deliv 25:321–9.
   PubMed Web of Science ®Google Scholar
• Hu CMJ, Zhang L. (2012). Nanoparticle-based combination therapy toward overcoming drug resistance in cancer. Biochem Pharmacol 83:1104–11.
   PubMed Web of Science ®Google Scholar
• Ibrahim N, Yu Y, Walsh WR, et al. (2012). Molecular targeted therapies for cancer: sorafenib monotherapy and its combination with other therapies. Oncol Rep 27:1303–11.
   PubMed Web of Science ®Google Scholar
• Ji X, Gao Y, Chen L, et al. (2012). Nanohybrid systems of non-ionic surfactant inserting liposomes loading paclitaxel for reversal of multidrug resistance. Int J Pharm 422:390–7.
   PubMed Web of Science ®Google Scholar
• Lehár J, Krueger AS, Avery W, et al. (2009). Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat Biotechnol 27:659–66.
   PubMed Web of Science ®Google Scholar
• Li YJ, Dong M, Kong FM, Zhou JP. (2015). Folate-decorated anticancer drug and magnetic nanoparticles encapsulated polymeric carrier for liver cancer therapeutics. Int J Pharm 489:83–90.
   PubMed Web of Science ®Google Scholar
• Meads MB, Gatenby RA, Dalton WS. (2009). Environment-mediated drug resistance: a major contributor to minimal residual disease. Nat Rev Cancer 9:665–74.
   PubMed Web of Science ®Google Scholar
• Mo R, Jiang T, Gu Z. (2014). Recent progress in multidrug delivery to cancer cells by liposomes. Nanomedicine (Lond) 9:1117–20.
   PubMed Web of Science ®Google Scholar
• Mondal A, Bennett LL. (2016). Resveratrol enhances the efficacy of sorafenib mediated apoptosis in human breast cancer MCF7 cells through ROS, cell cycle inhibition, caspase 3 and PARP cleavage. Biomed Pharmacother 84:1906–14.
   PubMed Web of Science ®Google Scholar
• Noh I, Kim HO, Choi J, et al. (2015). Co-delivery of paclitaxel and gemcitabine via CD44-targeting nanocarriers as a prodrug with synergistic antitumor activity against human biliary cancer. Biomaterials 53:763–74.
   PubMed Web of Science ®Google Scholar
• Pal HC, Baxter RD, Hunt KM, et al. (2015). Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells. Oncotarget 6:28296–311.
   PubMed Web of Science ®Google Scholar
• Renugalakshmi A, Vinothkumar TS, Kandaswamy D. (2011). Nanodrug delivery systems in dentistry: a review on current status and future perspectives. Curr Drug Deliv 8:586–94.
   PubMed Web of Science ®Google Scholar
• Shukla S, Ohnuma S, Ambudkar S. (2011). Improving cancer chemotherapy with modulators of ABC drug transporters. Curr Drug Targets 12:621–30.
   PubMed Web of Science ®Google Scholar
• Tai W, Qin B, Cheng K. (2010). Inhibition of breast cancer cell growth and invasiveness by dual silencing of HER-2 and VEGF. Mol Pharm 7:543–56.
   PubMed Web of Science ®Google Scholar
• Tan S, Zou C, Zhang W, et al. (2017). Recent developments ind-a-tocopheryl polyethylene glycol-succinate-based nanomedicine for cancer therapy. Drug Deliv 1:1831–42.
   Web of Science ®Google Scholar
• Yang YC, Cai J, Yin J, et al. (2016). Heparin-functionalized pluronic nanoparticles to enhance the antitumor efficacy of sorafenib in gastric cancers. Carbohydr Polym 136:782–90.
   PubMed Web of Science ®Google Scholar
• Yang X, Shi X, Ji J, Zhai G. (2018). Development of redox-responsive theranostic nanoparticles for near-infrared fluorescence imaging-guided photodynamic/chemotherapy of tumor. Drug Deliv 25:780–96.
   PubMed Web of Science ®Google Scholar
• Yin M, Bao Y, Gao X, et al. (2017). Redox/pH dual-sensitive hybrid micelles for targeting delivery and overcoming multidrug resistance of cancer. J Mater Chem B 5:2964–78.
   PubMed Web of Science ®Google Scholar
• Yin S, Huai J, Chen X, et al. (2015). Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid. Acta Biomater 26:274–85.
   PubMed Web of Science ®Google Scholar
• Yin T, Liu J, Zhao Z, et al. (2016). Smart nanoparticles with a detachable outer shell for maximized synergistic antitumor efficacy of therapeutics with varying physicochemical properties. J Control Rel 243:54–68.
   PubMed Web of Science ®Google Scholar
• Yin Q, Shen J, Chen L, et al. (2012). Overcoming multidrug resistance by co-delivery of Mdr-1 and survivin-targeting RNA with reduction-responsible cationic poly(β-amino esters). Biomaterials 33:6495–506.
   PubMed Web of Science ®Google Scholar
• Zhang X, Guo S, Fan R, et al. (2012). Dual-functional liposome for tumor targeting and overcoming multidrug resistance in hepatocellular carcinoma cells. Biomaterials 33:7103–14.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li F, Guo S, et al. (2014). Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells. Biomaterials 35:3650–65.
   PubMed Web of Science ®Google Scholar
• Zhao YZ, Dai DD, Lu CT, et al. (2013). Epirubicin loaded with propylene glycol liposomes significantly overcomes multidrug resistance in breast cancer. Cancer Lett 330:74–83.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Li Y, Yang X, et al. (2017). The reversion of anti-cancer drug antagonism of tamoxifen and docetaxel by the hyaluronic acid-decorated polymeric nanoparticles. Pharmacol Res 126:84–96.
   PubMed Web of Science ®Google Scholar
• Zhu J, Qiao M, Wang Q, et al. (2018). Dual-responsive polyplexes with enhanced disassembly and endosomal escape for efficient delivery of siRNA. Biomaterials 162:47–59.
   PubMed Web of Science ®Google Scholar